8AM3 image
Entry Detail
PDB ID:
8AM3
Keywords:
Title:
Cyclohexanone dehydrogenase (CDH) from Alicycliphilus denitrificans K601 - wildtype
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2022-08-02
Release Date:
2024-02-14
Method Details:
Experimental Method:
Resolution:
1.86 Å
R-Value Free:
0.20
R-Value Work:
0.17
Space Group:
P 43 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Fumarate reductase/succinate dehydrogenase flavoprotein domain protein
Chain IDs:A (auth: AAA), B (auth: BBB)
Chain Length:598
Number of Molecules:2
Biological Source:Alicycliphilus denitrificans K601
Primary Citation
Rational design of a cyclohexanone dehydrogenase for enhanced alpha , beta-desaturation and substrate specificity.
Chem Sci 15 4969 4980 (2024)
PMID: 38550701 DOI: 10.1039/d3sc04009g

Abstact

The selective α,β-desaturation of cyclic carbonyl compounds, which are found in the core of many steroid and bioactive molecules, using green chemistry is highly desirable. To achieve this task, we have for the first time described and solved the de novo structure of a member of the cyclohexanone dehydrogenase class of enzymes. The breadth of substrate specificity was investigated by assaying the cyclohexanone dehydrogenase, from Alicycliphilus denitrificans, against several cyclic ketones, lactones and lactams. To investigate substrate binding, a catalytic variant, Y195F, was generated and used to obtain a crystallographic complex with the natural substrate, cyclohexanone. This revealed substrate-active site interactions, as well as the proximity of the cofactor, flavin adenine dinucleotide, and enabled us to propose a mechanistic function to key amino acids. We then used molecular dynamic simulations to guide design to add functionality to the cyclohexanone dehydrogenase enzyme. The resulting W113A variant had overall improved enzyme activity and substrate scope, i.e., accepting the bulkier carbonyl compound, dihydrocoumarin. Structural analysis of the W113A variant revealed a broader, more open active site, which helped explain the modified substrate specificity. This work paves the way for future bespoke regioselective α,β-desaturation in the synthesis of important bioactive molecules via rational enzyme engineering.

Legend

Protein

Chemical

Disease

Primary Citation of related structures